COVID-19, Patents and Access to Healthcare: a French Perspective

Matthieu Dhenne (1)

1 Max Planck Institute for Innovation and Competition

While the coronavirus 19 (COVID-19) pandemic forced a large part of the world's population into quarantine, research into treatment and testing intensified. At the same time, patents have rarely been so much in the forefront: how can we ensure that access to care will not be hindered by patents? Should we opt for an ex-officio license, relax the conditions of this license, or even expropriate the patentees? A bill tabled on April 7, 2020 in the French “Assemblée Nationale” launches discussion in France.

Mots clés: license agreements; Patent law; access to healthcare

Domaines: Sciences de l'Homme et Société

Matthieu Dhenne. COVID-19, Patents and Access to Healthcare: a French Perspective. 2020. ⟨halshs-02970550⟩